Article summary
This week in psychedelic policy: Texas moves ahead with state-funded ibogaine trials, Eli Lilly buys AtaiBeckley for up to $3.8 billion, a Miami Beach doctor faces a manslaughter charge, and a DinΓ© Nation chapter asks the DEA to block commercial mescaline manufacturing. The post Psychedelic Policy Briefing: Week of July 20th, 2026 appeared first on Psychedelics Today.
Continue to the original publication for the complete article.